Who
James Treco
Director
Company insider
Files Form 4 as: Director, Tonix Pharmaceuticals Holding.
In numbers
- Trades disclosed
- 15
- Buys
- 3
- Sells
- 0
- Bought
- $19K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 14 Feb 2019
- Last trade
- 12 May 2026
- Last filed
- 14 May 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 12 May 2026filed 14 May 2026 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,700 at $0.00 | filing |
| 20 Aug 2025filed 20 Aug 2025 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $9,000250 at $36.00 | filing |
| 13 May 2025filed 15 May 2025 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
| 5 Feb 2025filed 28 Feb 2025 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Code J | $00.02 at $0.30 | filing |
| 23 May 2024filed 24 May 2024 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —104,621 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —60,000 at $0.00 | filing |
| 9 May 2022filed 11 May 2022 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —2,131,500 at $0.00 | filing |
| 10 May 2021filed 12 May 2021 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —270,882 at $0.00 | filing |
| 31 Aug 2020filed 1 Sep 2020 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $4,8955,500 at $0.89 | filing |
| 14 Aug 2020filed 17 Aug 2020 | TNXP Tonix Pharmaceuticals HoldingBiotechnology | SEC FORM 4 Bought | $4,7704,500 at $1.06 | filing |
| 4 May 2020filed 6 May 2020 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —112,500 at $0.00 | filing |
| 16 Mar 2020filed 18 Mar 2020 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —6,000 at $0.00 | filing |
| 6 May 2019filed 8 May 2019 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 | filing |
| 14 Feb 2019filed 19 Feb 2019 | TNXP Tonix Pharmaceuticals Holdingoption or derivative · Biotechnology | SEC FORM 4 Code A | —10,000 at $0.00 | filing |
News
Tonix Pharmaceuticals (TNXP) Stock Price, News & AnalysisTNXP · 247wallst.com · 22 Oct 2026Tonix Pharmaceuticals Sets 2027 Phase 1 Target For TNX-801 Vaccine CandidateTNXP · rttnews.com · 15 Oct 2026Tonix Pharmaceuticals Begins Building Lyme Disease Drug Facility in Hamilton, MontanaTNXP · matr.net · 12 Oct 2026
0 headlines in the last 90 days name James Treco; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.